Comparative Effectiveness of mRNA and Inactivated Whole-Virus Vaccines Against Coronavirus Disease 2019 Infection and Severe Disease in Singapore . (6th June 2022)

• Record Type: Journal Article
• Authors: Premikha, M; Chiew, Calvin J; Wei, Wycliffe E; Leo, Yee Sin; Ong, Benjamin; Lye, David Chien; Lee, Vernon J; Tan, Kelvin Bryan
• Is Part Of: Clinical infectious diseases. Volume 75:Number 8(2022)
• Page Start: 1442
• Page End: 1445
• Publication Date: 2022-06-06
• Subjects: COVID-19 -- SARS-CoV-2 -- vaccines -- mRNA vaccine -- inactivated vaccine; Communicable diseases -- Periodicals; 616.905
• DOI: 10.1093/cid/ciac288
• Languages: English
• ISSNs: 1058-4838

Abstract

Abstract: Compared with individuals vaccinated with Pfizer-BioNTech/Comirnaty, recipients of Sinovac-CoronaVac and Sinopharm were 2.37 (95% CI, 2.29–2.46) and 1.62 (95% CI, 1.43–1.85) times more likely to be infected with coronavirus disease 19, respectively, while individuals vaccinated with Moderna were 0.42 (95% CI, 0.25–0.70) times less likely to develop severe disease.